Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-049665
Filing Date
2015-08-14
Accepted
2015-08-14 14:39:32
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v417464_10-q.htm 10-Q 238655
2 EXHIBIT 31.1 v417464_ex31-1.htm EX-31.1 8753
3 EXHIBIT 31.2 v417464_ex31-2.htm EX-31.2 8943
4 EXHIBIT 32 v417464_ex32.htm EX-32 5121
  Complete submission text file 0001144204-15-049665.txt   2126927

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20150630.xml EX-101.INS 389888
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20150630.xsd EX-101.SCH 25094
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20150630_cal.xml EX-101.CAL 25790
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20150630_def.xml EX-101.DEF 140575
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20150630_lab.xml EX-101.LAB 193431
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20150630_pre.xml EX-101.PRE 168546
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28347 | Film No.: 151054958
SIC: 2834 Pharmaceutical Preparations